115 related articles for article (PubMed ID: 38224798)
1. Chitosan-coated magnetic graphene oxide for targeted delivery of doxorubicin as a nanomedicine approach to treat glioblastoma.
Dash BS; Lu YJ; Huang YS; Chen JP
Int J Biol Macromol; 2024 Mar; 260(Pt 1):129401. PubMed ID: 38224798
[TBL] [Abstract][Full Text] [Related]
2. Magnetic and GRPR-targeted reduced graphene oxide/doxorubicin nanocomposite for dual-targeted chemo-photothermal cancer therapy.
Dash BS; Lu YJ; Chen HA; Chuang CC; Chen JP
Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112311. PubMed ID: 34474862
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of irinotecan and SLP2 shRNA with GRP-conjugated magnetic graphene oxide for glioblastoma treatment.
Chuang CC; Lan YH; Lu YJ; Weng YL; Chen JP
Biomater Sci; 2022 Jun; 10(12):3201-3222. PubMed ID: 35579261
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-modified, IR780-conjugated and doxorubicin-loaded reduced graphene oxide for targeted cancer chemo/photothermal/photodynamic therapy.
Dash BS; Lu YJ; Pejrprim P; Lan YH; Chen JP
Biomater Adv; 2022 May; 136():212764. PubMed ID: 35929292
[TBL] [Abstract][Full Text] [Related]
5. Magnetic Graphene Oxide for Dual Targeted Delivery of Doxorubicin and Photothermal Therapy.
Lu YJ; Lin PY; Huang PH; Kuo CY; Shalumon KT; Chen MY; Chen JP
Nanomaterials (Basel); 2018 Mar; 8(4):. PubMed ID: 29584656
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
[TBL] [Abstract][Full Text] [Related]
7. Injectable Thermo-Sensitive Chitosan Hydrogel Containing CPT-11-Loaded EGFR-Targeted Graphene Oxide and SLP2 shRNA for Localized Drug/Gene Delivery in Glioblastoma Therapy.
Lu YJ; Lan YH; Chuang CC; Lu WT; Chan LY; Hsu PW; Chen JP
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993166
[TBL] [Abstract][Full Text] [Related]
8. Preparation of superparamagnetic iron oxide/doxorubicin loaded chitosan nanoparticles as a promising glioblastoma theranostic tool.
Gholami L; Tafaghodi M; Abbasi B; Daroudi M; Kazemi Oskuee R
J Cell Physiol; 2019 Feb; 234(2):1547-1559. PubMed ID: 30145790
[TBL] [Abstract][Full Text] [Related]
9. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
10. Layer-by-layer modification of magnetic graphene oxide by chitosan and sodium alginate with enhanced dispersibility for targeted drug delivery and photothermal therapy.
Xie M; Zhang F; Peng H; Zhang Y; Li Y; Xu Y; Xie J
Colloids Surf B Biointerfaces; 2019 Apr; 176():462-470. PubMed ID: 30682619
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
Wu J; Tang C; Yin C
Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral Delivery of Doxorubicin on Folate-Conjugated Graphene Oxide by In-Situ Forming Thermo-Sensitive Hydrogel for Breast Cancer Therapy.
Fong YT; Chen CH; Chen JP
Nanomaterials (Basel); 2017 Nov; 7(11):. PubMed ID: 29135959
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity.
Zhao Y; Ren W; Zhong T; Zhang S; Huang D; Guo Y; Yao X; Wang C; Zhang WQ; Zhang X; Zhang Q
J Control Release; 2016 Jan; 222():56-66. PubMed ID: 26682502
[TBL] [Abstract][Full Text] [Related]
14. PEGylated nano-graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity.
Pei X; Zhu Z; Gan Z; Chen J; Zhang X; Cheng X; Wan Q; Wang J
Sci Rep; 2020 Feb; 10(1):2717. PubMed ID: 32066812
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
16. Engineering the pH-Sensitivity of the Graphene and Carbon Nanotube Based Nanomedicines in Smart Cancer Therapy by Grafting Trimetyl Chitosan.
Khoshoei A; Ghasemy E; Poustchi F; Shahbazi MA; Maleki R
Pharm Res; 2020 Aug; 37(8):160. PubMed ID: 32747991
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
[TBL] [Abstract][Full Text] [Related]
18. Cyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In Vivo.
Chen W; Zou Y; Zhong Z; Haag R
Small; 2017 Feb; 13(6):. PubMed ID: 27865044
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
Hu FQ; Liu LN; Du YZ; Yuan H
Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395
[TBL] [Abstract][Full Text] [Related]
20. Triformyl cholic acid and folic acid functionalized magnetic graphene oxide nanocomposites: Multiple-targeted dual-modal synergistic chemotherapy/photothermal therapy for liver cancer.
Gong T; Wang X; Ma Q; Li J; Li M; Huang Y; Liang W; Su D; Guo R
J Inorg Biochem; 2021 Oct; 223():111558. PubMed ID: 34329998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
